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Abstract
Background: Gastric intestinal metaplasia (IM) is generally considered as a precancerous condition, a related risk
factor for intestinal-type gastric cancer. However, an accurate endoscopic diagnosis of IM is a clinical challenge.
Confocal Laser Endomicroscopy (CLE) is a newly technique that can provide real-time magnified images and
visualize tissues at cellular or subcellular levels. The aim of this study is to clarify the diagnostic value of CLE in
detection of IM in patients at high risk of gastric cancer.
Methods: Systematic literature searches up to April 2015 in PubMed, Embase, Web of Science, Cochrane Library
databases were conducted by two reviewers independently. The Quality Assessment of Diagnostic Accuracy
Studies-2 (QUADAS-2) tool was applied to assess study quality and to reduce potential bias. A meta-analysis using
Meta-Disc (version 1.4) and STATA software (version 13) was performed.
Results: A total of four studies enrolled 218 patients and 579 lesions were included in this meta-analysis. On per-lesion
basis, the pooled sensitivity and specificity of CLE were 0.97(95 % confidence interval (CI) = 0.94–0.98) and 0.94
(95 % CI = 0.91–0.97) respectively. The pooled positive likelihood ratio (PLR) and negative likelihood ratio (NLR)
were 15.20 (95 % CI = 9.46–24.41) and 0.04 (95 % CI = 0.02–0.07) respectively. The pooled diagnostic odds ratio (DOR)
was 479.59 (95 % CI = 205.64–1118.51) and summary receiver operating curve (SROC) area under the curve was 0.9884.
There was no statistical significance of publication bias.
Conclusion: CLE is a promising endoscopic tool in the detection of IM with the relatively high diagnostic value in
patients at high risk of gastric cancer.
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Background
Gastric cancer is an aggressive disease, which is the sec-
ond leading cause of cancer-related death globally [1]. It
is well acknowledged that the pathogenesis of stomach
cancer is a multi-step and sequential process beginning
with chronic atrophic gastritis, going through intestinal
metaplasia (IM), intraepithelial neoplasia and finally de-
veloping into adenocarcinoma [2–5]. The IM is generally
considered as a premalignant lesion contributing to the
development of gastric tumor [6, 7]. Current diagnosis
of IM is based on pathological assessment of biopsy
specimens with white-light endoscopy [8]. This conven-
tional method is time-consuming and inefficient. It fails
to detect IM whose mucosal surface looks normal. Im-
proved endoscopic techniques such as chromoendo-
scopy, magnifying endoscopy, narrow-band imaging
(NBI) technique have been shown to improve detection
and diagnosis of IM during endoscopy [9, 10]. Above all
techniques, however, are suboptimal for the detection of
IM. None of them can distinguish the structure of
individual cells or microstructures, and so pathologic as-
sessment is still required [11, 12]. Recently, a new endo-
scopic technique called Confocal Laser Endomicroscopy
(CLE) is applied to the detection of many gastrointes-
tinal diseases [13–16]. It combines conventional white-
light endoscopy with confocal laser microscopy and can
be divided into two types:endoscope-based CLE (e-CLE)
and probe-based CLE (p-CLE) [17]. The greatest advan-
tage of CLE is to simultaneously provide macroscopic
and microscopic images of the gastrointestinal epithelium
[18]. The CLE has been reported to reveal high diagnostic
value for digestive diseases [13, 14, 19, 20]. However, a
comprehensive systematic review of the diagnostic per-
formance of CLE on IM has not been reported.
In this meta-analysis, the goal is to establish diagnostic
accuracy of CLE in diagnosis of IM in the high-risk
group of gastric cancer.
Methods
Search strategy
A systematical search was conducted on PubMed, Web of
Science, Embase, Cochrane Library databases to collect
relevant articles published before April 2015. The search
terms were: (“confocal endoscopy” OR “confocal laser
endomicroscopy” OR “CLE”) AND (“IM” OR “intestinal
metaplasia”). To avoid missing studies, we also examined
the reference lists of all related articles for any additional
papers. Two authors extracted the data from these articles
independently. Authors of these articles were contacted
by email if further detailed information are needed.
Selection criteria
Articles were included in studies if they met all the fol-
lowing criteria: (1) using CLE to evaluate diagnostic
accuracy of IM; (2) containing available data for con-
structing contingency tables for true positive (TP), false
positive (FP), false negative (FN) and true negative (TN);
(3) applying histopathology as a reference standard.
Articles that met any one of the following criteria were
excluded: (1) Insufficient data to construct contingency
tables; (2) No histological diagnosis of lesions; (3) Re-
views, case reports, abstracts and editorials.
Data extraction and quality assessment
TP, FP, FN and TN from original studies were independ-
ently extracted to construct 2 × 2 tables by two re-
viewers. First author, publication year, country, number
of patients, number of lesions, patients’ ages, sex ratio,
histological diagnosis, number of endoscopists and en-
doscopes used from each studies were also extracted
from studies. Discrepancies were resolved by discussions.
The Quality Assessment of Diagnostic Accuracy Studies-2
(QUADAS-2) [21] was applied to assess study quality and
potential bias. The QUADAS-2 tool contains four key do-
mains that are rated in terms of the risk of bias. Quality
assessment of the included studies was performed by two
reviewers independently.
Statistical methods
Data were analyzed by Meta-Disc (version 1.4) and
STATA software (version 13). The pooled sensitivity,
specificity, PLR, NLR and DOR were estimated by a
fixed-effect model (Mantel–Haenszel method). Hetero-
geneity across the studies was tested by the Cochrane Q
test. Inconsistency (I2) was used to express the percent-
age variability attributable to heterogeneity. I2larger than
50 % indicates heterogeneity is statistically significant,
and P-values less than 0.1 illustrates the presence of het-
erogeneity among studies. The SROC and the area under
the curve (AUC) were also constructed to illustrate the
diagnostic precision of CLE. Finally, a funnel plot was
constructed by Deeks’ asymmetry test to evaluate publi-
cation bias of selected studies.
Results
Included studies
Four eligible studies were selected from the literature
after searching the databases [22–25]. Fig. 1 shows how
studies were screened from the literature. Overall 218
patients were enrolled in final analysis, with average of
54.5 patients per study (range from 20 to 85 patients).
Information of per-lesion but not per-patient analyses
was provided by all included studies. The CLE and
white-light endoscopy were used to diagnose IM in all of
included studies plus virtual chromoendoscopy was also
performed in one study [24]. Additionally, virtual chro-
moendoscopy magnifying flexible spectral imaging color
enhancement (ME-FICE) and p-CLE were applied to
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detect GIM in another study [20]. The main findings of
the studies were presented in Table 1.
Study characteristics and quality assessment
According to the QUADAS-2 criteria, the quality of the
inclueded studies was shown in Table 2. Generally, most
of included studies met the quality criteria.
Diagnostic performance of CLE
Based on the data from the four studies enrolling 218
participants and 579 lesions, the pooled sensitivity and
specificity of CLE on per-lesion level were 0.97 (95 % CI
=0.94–0.98) and 0.94 (95 % CI = 0.91–0.97) respectively
(Figs. 2a and b). The pooled PLR was 15.20 (95 % CI =
9.46–24.41), and the pooled NLR was 0.04 (95 % CI =
0.02–0.07) (Figs. 3a and b). The AUC and pooled DOR
were 0.9884 and 479.59 (95 % CI = 205.64–1118.51) re-
spectively (Figs. 4 and 5), indicating a high performance
of diagnostic accuracy for CLE in detection of IM among
the high-risk group of gastric cancer. The Cochran’s Q
and I2 for DOR were 2.23 (p = 0.527) and 0, respectively,
demonstrating low heterogeneity among the four studies
for a per-lesion analysis. Deeks’ funnel plot which was
not significantly asymmetrical (Fig. 6) illustrated no sig-
nificant publication bias in this meta-analysis.
Discussion
Gastric cancer is still one of the most prevalent and
lethal malignant diseases worldwide despite a decrease
in its incidence recent decades. Early diagnosis of gas-
tric cancer plays an important role in patients’ prog-
noses. Gastric intestinal metaplasia (IM) is a relatively
Fig. 1 Literature search flow diagram
Table 1 Characteristics of the selected studies
Study(Year) Country Numbers of
patients,n
Lesions
examined, n
Mean
age,year
M/
F*
Histological reference
standard
Endoscopists
Number,n
Type of CLE
system
Guo etal [27]
(2008)
China 53 267 51 38/
15
IM** 3 e-CLE
Zhen etal [29]
(2013)
China 85 67 55 45/
40
IM 3 e-CLE
Rapat etal[20]
(2013)
Thai land 60 120 62.8 33/
27
IM 5 P-CLE
Lim etal [19]
(2013)
Singapore 20 125 62.5 15/5 IM 1 P-CLE
IM intestinal metaplasia M/F male to female, CLE Confocal Laser Endomicroscopy, e-CLE endoscope-based, CLE P-CLE probe-based CLE
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frequent precancerous lesion and the progression rate
from IM to gastric cancer over 5 years varies from
1.25 to 42 % [19, 20]. Correa et al. reported that
incomplete-type IM should be followed by surveillance
in order to early diagnosis of dysplasia or early adeno-
carcinoma [26]. In this context, it may be justified to
monitor IM in some patients (such as positive H. pyl-
ori infection) at high risk of gastric cancer in order to
early detection [26, 27]. However, conventional WLE with
multiple random biopsies was unable to detect IM effect-
ively because of the significant sampling error [22, 28].
The CLE is a novel endoscopic technique for detec-
tion of the gastrointestinal mucosa in vivo with the
help of WLE by a microscopy. The new device is in-
tegrated into the distal site of the conventional endo-
scope and can also perform targeted biopsy and
virtual histological diagnosis with the help of WLE.
Although e-CLE is reported to have a better diagnosis
of Barrett’s esophagus and tumors compared with p-
CLE [29–31], p-CLE has gained more popularity in
detection of various gastrointestinal diseases recently
[32]. The p-CLE has a slightly lower resolution and
smaller field of view, nevertheless, it is more practical
because of greater versatility of its probes and faster
frame rate to acquire images [32]. Since microscopic
visualization of the gastrointestinal structures could be
provided by CLE, the diagnostic criteria of CLE on IM
corresponds well with histopathologic criteria. All studies
adopted the similar diagnostic criteria proposed by Guo et
al. in 2008 [22]. The IM can be identified in CLE if any
one of the following features is present in the image field:
goblet cells, villiform shape of foveolar epithelium and col-
umnar absorptive cells.
To our knowledge, our meta-analysis was first to
summarize the available evidence currently with re-
spect to the diagnostic value of CLE in characterizing
of IM. Due to insufficient data, it was impossible to
estimate diagnostic value of CLE on a per-patient
basis. As mentioned earlier, the summary sensitivity
and specificity of CLE were 0.97 (95 % CI = 0.94–
0.98) and 0.94 (95 % CI = 0.91–0.97) respectively. The
pooled DOR was 479.59 (95 % CI = 205.64–1118.51).
Fig. 2 Forest plot showing pooled sensitivity and specificity for CLE to diagnose IM. a forest plots of the sensitivity; b forest plots of the specificity
Table 2 Quality of articles using the QUADAS tool
Study Risk of bias Applicability Concerns
Patient selection Index test Reference standard Flow and timing Patient selection Index test Reference standard
Guo etal [27] (2008) L L L L L L L
Zhen etal [29] (2014) L L L L L L L
Rapat etal [20] (2013) H L L L H L L
Lim etal [19] (2013) L L L L L L L
L low risk; H high risk; U nuclear risk
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These statistical results indicated that CLE had a high
level of diagnostic accuracy for IM with the help of WLE.
Compared with NBI, which was considered as an
extremely useful diagnostic tool for IM [33], CLE had
higher sensitivity (96.7 % VS 69 %), similar specificity
(94 % VS 91 %) and similar AUC (99 % VS 90 %) on a per-
Fig. 4 SROC curve of CLE for IM. SROC, summary receiver operating characteristic, AUC: Area under curve; SE: Standard error
Fig. 3 Forest plot showing positive LR and negative LR of CLE for IM. a forest plots of the positive LR; b forest plots of the negative LR. LR,
likelihood ratio
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lesion basis [33]. Besides, biopsy examinations required
complex and time-consuming procedures. It should be
noted that the CLE may not be cost effective com-
pared with the conventional tool [23]. Targeted biopsy
by p-CLE was more efficient as less numbers of biop-
sies are required compared with conventional biopsies.
Zhen [23] reported that numbers of biopsies per pa-
tient by CLE targeting of biopsies could decrease 68 %
compared with standard biopsy protocol. We also
searched studies in order to evaluate the diagnostic accur-
acy of CLE for intraepithelial neoplasia (IN) in this study.
Unfortunately, there were few studies. Li [34] reported
that CLE had a higher sensitivity (88.9 %), specificity
(99.3 %) and accuracy (98.8 %) for identification of gastric
cancer or HGIN lesions than WLE diagnosis alone. These
data also favored to support that CLE was a promising
tool in characterizing of precancerous lesions and early
gastric cancer in vivo.
Several precautions should also be considered in this
study. First of all, the four studies included in this meta-
analysis all came from Asia. There were no similar re-
searches in other regions so far. So researches with high
quality data across multiple centers were imperative to
evaluate the effectiveness of CLE to diagnose IM. Sec-
ondly, not all data could be extracted from the abstracts
of studies, another factor of eliminating some studies. At
last, only studies published in English were included.
The selections might lead to an existing language bias
and missing some useful information.
Conclusion
In summary, CLE is a reliable technique to diagnose
IM with high accuracy according to our study. CLE
could be considered as a promising endoscopic tool
to characterize IM in patients with high risk of gas-
tric cancer.
Fig. 6 Deeks’ funnel plot to assess publication bias of selected studies
Fig. 5 Forest diagnostic odds ratio of CLE for IM
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